SSG Capital Advisors served as the investment banker to Infinity Pharmaceuticals in the sale of substantially all its assets to a healthcare investment firm. The sale was effectuated through a Chapter 11 Section 363 process in the U.S. Bankruptcy Court for the District of Delaware. The transaction closed in February 2024. Founded in 1995 and headquartered in Cambridge, MA, Infinity combines proven scientific expertise with a passion for developing small-molecule drugs that target specific disease pathways for potential applications in oncology.
Read the full article: Infinity Pharmaceuticals Sells Substantially All of Its Assets to Healthcare Investment Firm //
Source: https://www.abladvisor.com/news/38067/ssg-advises-infinity-pharmaceuticals-in-sale-of-substantially-all-assets-to-healt